Cardiovascular System Exam

Correct Answer: A

Rationale: Hypertrophic cardiomyopathy is the correct answer. It is a condition characterized by the abnormal thickening of the heart muscle without an obvious cause, which impairs the heart's ability to effectively pump blood. Dilated cardiomyopathy (choice B) involves the enlargement and weakening of the heart chambers, not thickening. Restrictive cardiomyopathy (choice C) refers to the stiffening of the heart muscle, limiting its ability to fill properly. Myocarditis (choice D) is inflammation of the heart muscle usually caused by a viral infection, not thickening.

Correct Answer: A

Rationale: The correct answer is A: Ischemic stroke. Ischemic stroke occurs when a blood clot blocks an artery supplying blood to the brain, leading to brain damage. Choice B, Hemorrhagic stroke, is caused by bleeding in the brain, not a blockage. Choice C, Transient ischemic attack, is a temporary blockage of blood flow to the brain with symptoms similar to a stroke but typically lasting only a few minutes. Choice D, Embolism, refers to a blood clot or other particle that travels through the bloodstream and blocks a blood vessel.

Correct Answer: A

Rationale: The correct answer is Purkinje fibers. Purkinje fibers are specialized conducting fibers that distribute the electrical impulse to the ventricles, leading to their contraction. The SA node (sinoatrial node) is responsible for initiating the electrical impulse in the heart, the AV node (atrioventricular node) delays the impulse to allow for proper atrial contraction before ventricular contraction, and the Bundle of His transmits the impulse from the AV node to the ventricles. Therefore, choices B, C, and D are not the correct options for fibers directly distributing the impulse to the ventricles.

Correct Answer: A

Rationale: The correct answer is A: Platelet count. When administering enoxaparin (Lovenox), it is crucial to monitor the platelet count because enoxaparin can cause a rare but serious side effect known as heparin-induced thrombocytopenia, which is a decrease in platelet count that can lead to increased risk of bleeding. Monitoring the platelet count allows for early detection of this potential complication. Choices B, C, and D are incorrect because aPTT, Hemoglobin, and INR are not the most important lab values to monitor specifically when administering enoxaparin.

Correct Answer: A

Rationale: The correct answer is A, Arrhythmia. Arrhythmia refers to an irregular heartbeat caused by the malfunction of the heart's electrical system. Bradycardia (choice B) is a condition characterized by a slow heart rate, while Tachycardia (choice C) is a condition characterized by a fast heart rate. Ventricular fibrillation (choice D) is a life-threatening arrhythmia where the heart's lower chambers quiver erratically.